ENTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.89%

Insider Buying (Last 12 Months): $256,050.00

Insider Selling (Last 12 Months): $306,026.21

Enanta Pharmaceuticals Insider Trading History Chart

Enanta Pharmaceuticals Share Price & Price History

^$5.37

▲ +0.19 (3.67%)

As of 05/15/2025 05:00 PM ET

Days: 30 | 90 | 365

Enanta Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/12/2025	Jay R. Luly	CEO	Buy	45,000	$5.69	$256,050.00	846,638
12/6/2024	Jay R. Luly	CEO	Sell	5,142	$8.06	$41,444.52	801,638
12/6/2024	Tara Lynn Kieffer	Insider	Sell	2,283	$8.06	$18,400.98	29,305
7/15/2024	Scott T Rottinghaus	Insider	Sell	5,375	$17.08	$91,805.00	21,717
7/11/2024	Scott T Rottinghaus	Insider	Sell	4,299	$15.07	$64,785.93	23,988
6/17/2024	Tara Lynn Kieffer	Insider	Sell	7,266	$12.33	$89,589.78	32,341
12/13/2023	Terry Vance	Director	Sell	15,295	$9.12	$139,490.40	5,800
12/5/2023	Brendan Luu	VP	Sell	2,125	$9.63	$20,463.75	36,736
12/5/2023	Jay R. Luly	CEO	Sell	7,230	$9.63	$69,624.90	806,793
12/5/2023	Paul J Mellett	CFO	Sell	2,412	$9.63	$23,227.56	93,549
12/5/2023	Scott T Rottinghaus	CMO	Sell	534	$9.63	$5,142.42	26,466
3/15/2023	Paul J Mellett	CFO	Sell	10,440	$44.43	$463,849.20	97,556
3/15/2023	Yat Sun Or	VP	Sell	13,925	$44.45	$618,966.25	374,702
3/13/2023	Jay R. Luly	CEO	Sell	27,912	$45.16	$1,260,505.92	819,810
2/9/2023	Paul J Mellett	CFO	Sell	5,000	$53.76	$268,800.00	83,463
12/16/2022	Jay R. Luly	CEO	Sell	30,000	$44.72	$1,341,600.00	773,805

See Full Table

SEC Filings (Institutional Ownership Changes) for Enanta Pharmaceuticals (NASDAQ:ENTA)

94.99% of Enanta Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enanta Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/15/2025	Trexquant Investment LP	290,059	$1.60M	0.0%	+113.4%	1.360%
5/14/2025	Ieq Capital LLC	41,997	$0.23M	0.0%	N/A	0.197%
5/14/2025	MetLife Investment Management LLC	13,079	$72K	0.0%	N/A	0.061%
5/14/2025	Stonepine Capital Management LLC	590,742	$3.26M	3.1%	+78.0%	2.769%
5/14/2025	Walleye Capital LLC	27,318	$0.15M	0.0%	+63.8%	0.128%
5/14/2025	AlphaQuest LLC	8,636	$48K	0.0%	-61.2%	0.040%
5/13/2025	American Century Companies Inc.	40,004	$0.22M	0.0%	+8.2%	0.188%
5/12/2025	Nuveen LLC	56,671	$0.31M	0.0%	N/A	0.266%
5/12/2025	Invesco Ltd.	60,277	$0.33M	0.0%	+29.3%	0.283%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	30,465	$0.17M	0.0%	+23.7%	0.143%
5/9/2025	Charles Schwab Investment Management Inc.	159,801	$0.88M	0.0%	+3.2%	0.749%
5/8/2025	US Bancorp DE	6,500	$36K	0.0%	N/A	0.030%
5/8/2025	XTX Topco Ltd	19,941	$0.11M	0.0%	N/A	0.093%
5/7/2025	Corton Capital Inc.	13,921	$77K	0.3%	N/A	0.065%
5/1/2025	CWM LLC	17,585	$97K	0.0%	+763.7%	0.082%
4/29/2025	Bank of New York Mellon Corp	53,248	$0.29M	0.0%	-6.8%	0.250%
4/15/2025	Assenagon Asset Management S.A.	112,672	$0.62M	0.0%	-41.6%	0.528%
4/8/2025	Rhumbline Advisers	31,140	$0.17M	0.0%	-16.0%	0.146%
4/7/2025	GAMMA Investing LLC	7,297	$40K	0.0%	N/A	0.034%
3/24/2025	Wellington Management Group LLP	51,298	$0.30M	0.0%	+47.6%	0.240%
2/19/2025	Public Employees Retirement System of Ohio	15,726	$90K	0.0%	+117.7%	0.074%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	159,729	$0.92M	0.0%	-6.4%	0.749%
2/17/2025	Velan Capital Investment Management LP	13,000	$75K	0.1%	N/A	0.061%
2/17/2025	Squarepoint Ops LLC	11,558	$66K	0.0%	N/A	0.054%
2/17/2025	Two Sigma Investments LP	64,283	$0.37M	0.0%	-66.4%	0.301%
2/17/2025	Two Sigma Advisers LP	156,300	$0.90M	0.0%	-32.9%	0.733%
2/17/2025	Stonepine Capital Management LLC	331,900	$1.91M	1.5%	N/A	1.556%
2/17/2025	Sherbrooke Park Advisers LLC	33,451	$0.19M	0.1%	N/A	0.157%
2/17/2025	Millennium Management LLC	896,987	$5.16M	0.0%	+22.7%	4.205%
2/17/2025	Jacobs Levy Equity Management Inc.	290,011	$1.67M	0.0%	+51.3%	1.360%
2/17/2025	D. E. Shaw & Co. Inc.	421,594	$2.42M	0.0%	-15.9%	1.977%
2/17/2025	Cubist Systematic Strategies LLC	20,255	$0.12M	0.0%	-11.6%	0.095%
2/17/2025	Bridgeway Capital Management LLC	46,200	$0.27M	0.0%	-3.8%	0.217%
2/17/2025	Bank of America Corp DE	8,022	$46K	0.0%	-98.9%	0.038%
2/17/2025	BNP Paribas Financial Markets	71,104	$0.41M	0.0%	+100.8%	0.333%
2/17/2025	Ameriprise Financial Inc.	70,427	$0.41M	0.0%	-78.5%	0.330%
2/14/2025	RA Capital Management L.P.	1,038,000	$5.97M	0.1%	N/A	4.866%
2/14/2025	Caligan Partners LP	184,826	$1.06M	0.3%	-42.7%	0.866%
2/14/2025	Jane Street Group LLC	31,072	$0.18M	0.0%	+34.1%	0.146%
2/14/2025	Northern Trust Corp	387,376	$2.23M	0.0%	-27.8%	1.816%
2/14/2025	Oxford Asset Management LLP	23,762	$0.14M	0.1%	N/A	0.111%
2/14/2025	Boothbay Fund Management LLC	85,649	$0.49M	0.0%	-42.7%	0.401%
2/14/2025	Susquehanna Fundamental Investments LLC	18,346	$0.11M	0.0%	N/A	0.086%
2/14/2025	Tower Research Capital LLC TRC	7,202	$41K	0.0%	+46.1%	0.034%
2/14/2025	Dimensional Fund Advisors LP	297,106	$1.71M	0.0%	+52.8%	1.393%
2/13/2025	Marshall Wace LLP	930,087	$5.35M	0.0%	+9.3%	4.360%
2/13/2025	Walleye Capital LLC	16,679	$96K	0.0%	-62.0%	0.078%
2/13/2025	Barclays PLC	45,508	$0.26M	0.0%	+65.9%	0.213%
2/13/2025	Renaissance Technologies LLC	498,000	$2.86M	0.0%	-5.1%	2.335%
2/13/2025	Invesco Ltd.	46,614	$0.27M	0.0%	+7.3%	0.219%
2/13/2025	Bank of Montreal Can	31,748	$0.18M	0.0%	N/A	0.149%
2/13/2025	Federated Hermes Inc.	8,534	$49K	0.0%	-90.3%	0.040%
2/13/2025	Russell Investments Group Ltd.	14,416	$83K	0.0%	-17.7%	0.068%
2/13/2025	Wells Fargo & Company MN	15,881	$91K	0.0%	+69.6%	0.074%
2/12/2025	Trexquant Investment LP	135,954	$0.78M	0.0%	+97.3%	0.637%
2/12/2025	Wellington Management Group LLP	51,298	$0.30M	0.0%	+47.6%	0.240%
2/12/2025	Norges Bank	40,700	$0.23M	0.0%	N/A	0.191%
2/12/2025	JPMorgan Chase & Co.	163,113	$0.94M	0.0%	-33.0%	0.765%
2/11/2025	Prudential Financial Inc.	60,364	$0.35M	0.0%	-61.6%	0.283%
2/11/2025	American Century Companies Inc.	36,962	$0.21M	0.0%	+10.5%	0.173%
2/11/2025	Intech Investment Management LLC	10,092	$58K	0.0%	N/A	0.047%
2/10/2025	Thrivent Financial for Lutherans	44,102	$0.25M	0.0%	N/A	0.207%
2/7/2025	AlphaQuest LLC	22,260	$0.13M	0.0%	+16.4%	0.104%
2/6/2025	Charles Schwab Investment Management Inc.	154,827	$0.89M	0.0%	-4.7%	0.726%
1/24/2025	China Universal Asset Management Co. Ltd.	4,494	$26K	0.0%	N/A	0.021%
1/14/2025	Assenagon Asset Management S.A.	192,856	$1.11M	0.0%	+34.1%	0.910%
12/26/2024	JPMorgan Chase & Co.	243,628	$2.52M	0.0%	+53.7%	1.150%
11/19/2024	Barclays PLC	27,438	$0.29M	0.0%	+294.2%	0.129%
11/16/2024	Geode Capital Management LLC	477,351	$4.95M	0.0%	+3.1%	2.253%
11/15/2024	Barclays PLC	27,438	$0.29M	0.0%	+294.2%	0.129%
11/15/2024	Krensavage Asset Management LLC	1,498,074	$15.52M	8.7%	+19.7%	7.070%
11/15/2024	Jane Street Group LLC	23,176	$0.24M	0.0%	-19.2%	0.109%
11/15/2024	Wellington Management Group LLP	34,751	$0.36M	0.0%	N/A	0.164%
11/15/2024	State Street Corp	449,975	$4.66M	0.0%	+6.4%	2.124%
11/15/2024	Point72 Asset Management L.P.	87,190	$0.90M	0.0%	N/A	0.411%
11/15/2024	Jacobs Levy Equity Management Inc.	191,726	$1.99M	0.0%	-1.5%	0.905%
11/15/2024	Erste Asset Management GmbH	120,000	$1.24M	0.0%	N/A	0.566%
11/14/2024	Caligan Partners LP	322,453	$3.34M	1.1%	-69.1%	1.522%
11/14/2024	PDT Partners LLC	33,342	$0.35M	0.0%	-8.0%	0.157%
11/14/2024	Walleye Capital LLC	43,899	$0.46M	0.0%	+96.4%	0.207%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	170,615	$1.77M	0.0%	-13.9%	0.805%
11/13/2024	FMR LLC	49,301	$0.51M	0.0%	+18.9%	0.233%
11/12/2024	Valence8 US LP	19,939	$0.21M	0.1%	N/A	0.094%
11/12/2024	Charles Schwab Investment Management Inc.	162,398	$1.68M	0.0%	-1.0%	0.766%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	11,768	$0.12M	0.0%	N/A	0.056%
11/7/2024	Quest Partners LLC	19,123	$0.20M	0.0%	+65.0%	0.090%
10/28/2024	US Bancorp DE	4,329	$45K	0.0%	+4,933.7%	0.020%
10/23/2024	Assenagon Asset Management S.A.	143,806	$1.49M	0.0%	-66.3%	0.679%
9/16/2024	Cubist Systematic Strategies LLC	45,350	$0.59M	0.0%	+65.8%	0.214%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	14,326	$0.19M	0.0%	-43.2%	0.068%
8/15/2024	Millennium Management LLC	683,143	$8.86M	0.0%	-3.3%	3.226%
8/15/2024	AQR Capital Management LLC	60,005	$0.78M	0.0%	-45.3%	0.283%
8/15/2024	Armistice Capital LLC	1,096,000	$14.22M	0.2%	-11.3%	5.175%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	14,326	$0.19M	0.0%	-43.2%	0.068%
8/14/2024	Cubist Systematic Strategies LLC	45,350	$0.59M	0.0%	+65.8%	0.214%
8/14/2024	Marshall Wace LLP	928,363	$12.04M	0.0%	-2.4%	4.383%
8/13/2024	Sei Investments Co.	72,925	$0.95M	0.0%	-17.3%	0.344%
8/12/2024	Hsbc Holdings PLC	18,086	$0.23M	0.0%	-11.3%	0.085%
8/9/2024	Renaissance Technologies LLC	510,900	$6.63M	0.0%	-2.9%	2.412%
8/9/2024	Dimensional Fund Advisors LP	129,062	$1.67M	0.0%	-31.8%	0.609%

Data available starting January 2016

See Full Table

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $5.37

$5.04

$5.38

50 Day Range

MA: $5.55

$4.26

$7.27

52 Week Range

Now: $5.37

$4.09

$17.24

Volume

81,390 shs

Average Volume

285,314 shs

Market Capitalization

$114.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of Enanta Pharmaceuticals?: Enanta Pharmaceuticals' top insider shareholders include:
Jay R Luly (CEO)
Paul J Mellett (CFO)
Brendan Luu (VP)
Tara Lynn Kieffer (Insider)
Scott T Rottinghaus (CMO)
Scott T Rottinghaus (Insider)
Terry Vance (Director)
Learn More about top insider investors at Enanta Pharmaceuticals.
Who are the major institutional investors of Enanta Pharmaceuticals?: Enanta Pharmaceuticals' top institutional investors include:
Charles Schwab Investment Management Inc. — 0.75%
Assenagon Asset Management S.A. — 0.53%
Invesco Ltd. — 0.28%
Nuveen LLC — 0.27%
Bank of New York Mellon Corp — 0.25%
American Century Companies Inc. — 0.19%
Learn More about top institutional investors of Enanta Pharmaceuticals stock.
Which major investors are selling Enanta Pharmaceuticals stock?: During the last quarter, ENTA stock was sold by these institutional investors:
Assenagon Asset Management S.A.
AlphaQuest LLC
Rhumbline Advisers
Bank of New York Mellon Corp
Simplex Trading LLC
In the last year, company insiders that have sold Enanta Pharmaceuticals company stock include:
Jay R Luly (CEO)
Paul J Mellett (CFO)
Brendan Luu (VP)
Learn More investors selling Enanta Pharmaceuticals stock.
Which major investors are buying Enanta Pharmaceuticals stock?: During the previous quarter, ENTA stock was bought by institutional investors including:
Nuveen LLC
XTX Topco Ltd
CWM LLC
Corton Capital Inc.
Invesco Ltd.
GAMMA Investing LLC
US Bancorp DE
Connor Clark & Lunn Investment Management Ltd.